Literature DB >> 17082242

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.

Xiaoyue Tan1, Yingjian Li, Youhua Liu.   

Abstract

Deficiency in vitamin D and its active metabolites is a pathologic feature of chronic kidney diseases. Despite that tubular epithelial cells are the major sites of active vitamin D synthesis, little is known about the role of vitamin D in maintaining the structural and functional integrity of tubular epithelium. This study investigated the effects of paricalcitol (19-nor-1,25-hydroxy-vitamin D(2)), a synthetic vitamin D analogue, on obstructive nephropathy, a model that is characterized by predominant tubulointerstitial lesions. Compared with vehicle controls, paricalcitol significantly attenuated renal interstitial fibrosis in mouse kidney after ureteral obstruction, as demonstrated by a reduced interstitial volume, decreased collagen deposition, and repressed mRNA expression of fibronectin and type I and type III collagens. Paricalcitol largely preserved E-cadherin and reduced alpha-smooth muscle actin expression in vivo. In addition, paricalcitol suppressed renal TGF-beta1 and its type I receptor expression, restored vitamin D receptor abundance, and inhibited cell proliferation and apoptosis after obstructive injury. In vitro, paricalcitol abolished TGF-beta1-mediated E-cadherin suppression and alpha-smooth muscle actin and fibronectin induction in tubular epithelial cells, underscoring its ability to block directly the epithelial to mesenchymal transition (EMT). It is interesting that paricalcitol almost completely suppressed renal induction of Snail, a critical transcription factor that is implicated in EMT programming. Furthermore, paricalcitol inhibited the TGF-beta1-mediated Snail induction in vitro, and ectopic expression of Snail repressed E-cadherin promoter activity and downregulated E-cadherin expression in tubular epithelial cells. These studies suggest that paricalcitol is able to ameliorate renal interstitial fibrosis in obstructive nephropathy, possibly by preserving tubular epithelial integrity through suppression of EMT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082242     DOI: 10.1681/ASN.2006050520

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  104 in total

Review 1.  Can vitamin D slow down the progression of chronic kidney disease?

Authors:  Rukshana Shroff; Mandy Wan; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2011-12-10       Impact factor: 3.714

Review 2.  Nuclear receptors in renal disease.

Authors:  Moshe Levi
Journal:  Biochim Biophys Acta       Date:  2011-04-14

Review 3.  Cellular and molecular mechanisms of renal fibrosis.

Authors:  Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

4.  1,25-Dihydroxyvitamin D₃ suppresses inflammation-induced expression of plasminogen activator inhibitor-1 by blocking nuclear factor-κB activation.

Authors:  Yunzi Chen; Juan Kong; Tao Sun; George Li; Frances L Szeto; Weicheng Liu; Dilip K Deb; Youli Wang; Qun Zhao; Ravi Thadhani; Yan Chun Li
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

5.  22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.

Authors:  Misaki Hirose; Tomoya Nishino; Yoko Obata; Masayuki Nakazawa; Yuka Nakazawa; Akira Furusu; Katsushige Abe; Masanobu Miyazaki; Takehiko Koji; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

6.  Vitamin D Attenuates Kidney Fibrosis via Reducing Fibroblast Expansion, Inflammation, and Epithelial Cell Apoptosis.

Authors:  Nur Arfian; Khusnul Muflikhah; Sri Kadarsih Soeyono; Dwi Cahyani Ratna Sari; Untung Tranggono; Nungki Anggorowati; Muhammad Mansyur Romi
Journal:  Kobe J Med Sci       Date:  2016-07-05

7.  1,25-(OH)2D3 and its analogue BXL-628 inhibit high glucose-induced activation of RhoA/ROCK pathway in HK-2 cells.

Authors:  Wei Zhang; Bin Yi; Ke Zhang; Aimei Li; Shikun Yang; Jing Huang; Jishi Liu; Hao Zhang
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

8.  Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing?

Authors:  Inês Correia-Sá; Paula Serrão; Marisa Marques; Maria A Vieira-Coelho
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

9.  Wnt/beta-catenin signaling promotes renal interstitial fibrosis.

Authors:  Weichun He; Chunsun Dai; Yingjian Li; Gang Zeng; Satdarshan P Monga; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

Review 10.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.